Dose-dependent absorption and elimination of cefadroxil in man
The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased si...
Saved in:
Published in | European journal of clinical pharmacology Vol. 41; no. 2; p. 179 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.01.1991
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased significantly from 15.1 to 10.7 and 7.6 mg.l-1, while the corresponding normalized areas under the plasma concentration-time curves from 0 to 2 h decreased significantly from 1258 to 946 and 801 min.mg.l-1. When the same subjects were given 5 mg.kg-1 of cefadroxil together with 45 mg.kg-1 of cephalexin, the absorption of cefadroxil was slowed to a similar or greater extent than with the high dose of cefadroxil. Although the absorption rate decreased as the dose increased, the systemic availability of cefadroxil was essentially complete at all doses, as judged by the 24 h urinary recoveries of the antibiotic. Kinetic analysis of the plasma concentration-time curves gave the best fit with a zero-order followed by a first-order absorption process, consistent with saturable intestinal absorption of cefadroxil. The elimination rate of cefadroxil was directly related to dose and plasma concentrations, and the clearance at the dose of 5 mg.kg-1 was significantly increased by the simultaneous administration of high-dose cephalexin. The renal clearance of cefadroxil ranged from 98 ml.min.l-1 at total plasma cephalosporin (cefadroxil + cephalexin) concentrations less than 2.5 mg.l-1 to 156 mg.l-1 at concentrations greater than 40 mg.l-1. |
---|---|
AbstractList | The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased significantly from 15.1 to 10.7 and 7.6 mg.l-1, while the corresponding normalized areas under the plasma concentration-time curves from 0 to 2 h decreased significantly from 1258 to 946 and 801 min.mg.l-1. When the same subjects were given 5 mg.kg-1 of cefadroxil together with 45 mg.kg-1 of cephalexin, the absorption of cefadroxil was slowed to a similar or greater extent than with the high dose of cefadroxil. Although the absorption rate decreased as the dose increased, the systemic availability of cefadroxil was essentially complete at all doses, as judged by the 24 h urinary recoveries of the antibiotic. Kinetic analysis of the plasma concentration-time curves gave the best fit with a zero-order followed by a first-order absorption process, consistent with saturable intestinal absorption of cefadroxil. The elimination rate of cefadroxil was directly related to dose and plasma concentrations, and the clearance at the dose of 5 mg.kg-1 was significantly increased by the simultaneous administration of high-dose cephalexin. The renal clearance of cefadroxil ranged from 98 ml.min.l-1 at total plasma cephalosporin (cefadroxil + cephalexin) concentrations less than 2.5 mg.l-1 to 156 mg.l-1 at concentrations greater than 40 mg.l-1. |
Author | Garrigues, T M Prescott, L F Peris-Ribera, J E Martin, U |
Author_xml | – sequence: 1 givenname: T M surname: Garrigues fullname: Garrigues, T M organization: Department of Pharmacology and Pharmaceutics, University of Valencia, Spain – sequence: 2 givenname: U surname: Martin fullname: Martin, U – sequence: 3 givenname: J E surname: Peris-Ribera fullname: Peris-Ribera, J E – sequence: 4 givenname: L F surname: Prescott fullname: Prescott, L F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/1743250$$D View this record in MEDLINE/PubMed |
BookMark | eNotj8tOwzAURL0oKm1hwx7JPxC4fsX2BgkKBaRKbGBd3cTXklFiR0mQ4O95dTWasxidWbNFLpkYuxBwJQDs9d0OQNbGC71gKwAlqtpbOGXraXoHEMaDWrKlsFpJAyt2c18mqgINlAPlmWMzlXGYU8kcc-DUpT5l_Osl8pYihrF8po6nzHvMZ-wkYjfR-TE37G338Lp9qvYvj8_b233VKmXmyiqpgZw0SBiDNWSc1Y1GSejaH9Q6g76uTXS6Vr_y0kUDwaPx1EQT5YZd_u8OH01P4TCMqcfx63D8Ib8BwNRIyQ |
CitedBy_id | crossref_primary_10_1021_mp100130b crossref_primary_10_3389_fphar_2021_692741 crossref_primary_10_1007_s11095_013_1168_3 crossref_primary_10_1124_dmd_105_006791 crossref_primary_10_1007_s11095_012_0937_8 crossref_primary_10_1208_s12249_024_02811_z crossref_primary_10_1007_s11095_023_03597_8 crossref_primary_10_1016_0378_5173_94_00397_N crossref_primary_10_1016_0378_5173_95_04342_X crossref_primary_10_1177_0091270002250613 crossref_primary_10_1016_j_etap_2014_10_007 crossref_primary_10_1016_j_bcp_2016_03_008 crossref_primary_10_1124_dmd_107_015263 crossref_primary_10_1517_17425255_2_4_505 crossref_primary_10_1124_jpet_104_073098 crossref_primary_10_1021_mp500497p crossref_primary_10_1111_j_1365_2710_2010_01206_x crossref_primary_10_3109_00498254_2015_1080881 crossref_primary_10_1007_s00424_004_1326_x crossref_primary_10_1034_j_1600_0773_2002_900601_x crossref_primary_10_1007_s10928_022_09832_w crossref_primary_10_1124_dmd_118_084236 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1007/BF00265914 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 1743250 |
Genre | Clinical Trial Randomized Controlled Trial Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 6PF 78A 7RV 7X7 88E 8AO 8FI 8FJ 8FW 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYOK AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADOJX ADRFC ADTPH ADURQ ADYFF ADYOE ADYPR ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS ECM ECT EIF EIHBH EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- MK0 N2Q N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 WOW Y6R YLTOR Z45 Z7U Z7V Z7W Z81 Z82 Z83 Z87 Z8O Z8P Z8Q Z8U Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM |
ID | FETCH-LOGICAL-c335t-73240e825aeafd75e5874b4a2ea8ceafc85a9665f8463659128f50d9a59ebf5f2 |
ISSN | 0031-6970 |
IngestDate | Wed Feb 19 00:33:43 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c335t-73240e825aeafd75e5874b4a2ea8ceafc85a9665f8463659128f50d9a59ebf5f2 |
PMID | 1743250 |
ParticipantIDs | pubmed_primary_1743250 |
PublicationCentury | 1900 |
PublicationDate | 1991-01-01 |
PublicationDateYYYYMMDD | 1991-01-01 |
PublicationDate_xml | – month: 01 year: 1991 text: 1991-01-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | European journal of clinical pharmacology |
PublicationTitleAlternate | Eur J Clin Pharmacol |
PublicationYear | 1991 |
References | 3890912 - Br J Clin Pharmacol. 1985;19 Suppl 2:77S-83S 6491864 - J Pharmacobiodyn. 1984 Jul;7(7):452-64 41551 - Br J Clin Pharmacol. 1979 Oct;8(4):372-3 3912193 - Eur J Clin Pharmacol. 1985;29(4):495-502 445952 - Clin Pharmacol Ther. 1979 Jun;25(6):870-6 7264924 - J Pharm Sci. 1981 Jul;70(7):768-72 6225863 - J Pharmacobiodyn. 1983 Apr;6(4):246-53 7061182 - Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):73-7 7328489 - J Pharmacobiodyn. 1981 Nov;4(11):879-85 2568445 - J Pharm Pharmacol. 1989 Mar;41(3):179-85 7073267 - Antimicrob Agents Chemother. 1982 Feb;21(2):320-2 |
References_xml | – reference: 6225863 - J Pharmacobiodyn. 1983 Apr;6(4):246-53 – reference: 3890912 - Br J Clin Pharmacol. 1985;19 Suppl 2:77S-83S – reference: 7061182 - Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):73-7 – reference: 3912193 - Eur J Clin Pharmacol. 1985;29(4):495-502 – reference: 2568445 - J Pharm Pharmacol. 1989 Mar;41(3):179-85 – reference: 6491864 - J Pharmacobiodyn. 1984 Jul;7(7):452-64 – reference: 445952 - Clin Pharmacol Ther. 1979 Jun;25(6):870-6 – reference: 7073267 - Antimicrob Agents Chemother. 1982 Feb;21(2):320-2 – reference: 7264924 - J Pharm Sci. 1981 Jul;70(7):768-72 – reference: 7328489 - J Pharmacobiodyn. 1981 Nov;4(11):879-85 – reference: 41551 - Br J Clin Pharmacol. 1979 Oct;8(4):372-3 |
SSID | ssj0015903 |
Score | 1.494039 |
Snippet | The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 179 |
SubjectTerms | Absorption Adolescent Adult Cefadroxil - pharmacokinetics Cefadroxil - urine Cephalexin - pharmacokinetics Dose-Response Relationship, Drug Drug Interactions Humans Kidney - metabolism Male Metabolic Clearance Rate Reference Values |
Title | Dose-dependent absorption and elimination of cefadroxil in man |
URI | https://www.ncbi.nlm.nih.gov/pubmed/1743250 |
Volume | 41 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NaxsxEBVxQsGXkn6YtkmDDiWXWsWrlbzaSyCkKaY0xRQbfDP6BEPrNbYLbX99RivZWid1SHtZFgnE7r7nYWY88wahd9qPbRfKEJrbHmFSGiKZEkQWhuVaaUHroX03X_uDMfs84ZOUyq67S9bqg_7z176S_0EV1gBX3yX7D8huD4UFuAd84QoIw_VRGH-sVpZsxtiu30u1qpbBBPh0uP1eT-zauITaOmmW1a-ZV9nwVat7k_LRQd02TS6SvHWq_ZRLiOt_BiMzSjnVJEswTlYXDAn55ktTQmFu6n7wBSA6lox8iUXGJvbkZY0URDSreUb6ZZgAsjGrLGvQhzZsZBamx9yz3b1NRTqEhbwMraUNEBc_ahR9BEWDVu2Dm3dUtONOC7UgnPDzUX1SJ_7ZxMte1GYOb7GrYhufpo2exDPuBCC1IzI6Rk9jBIEvAx2eoQM7f47OhwGj3108Sh11qy4-x8MGei_QxS5ncOIMBs7gBmdw5XDiDJ7NMXDmJRp_uh5dDUicoUF0nvM1KbzgohWUSyudKbjlomCKSWql0LCkBZcQ8XInvHIcvCgVjvdMKXlpleOOdtDhvJrbVwj34QgB_q02tGDguAudF85k_ZIXipeOvUad8F2miyCUMo0f7M2-jRPUTnQ6RUcOfpf2LTh5a3VWQ3QLiOxRCQ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dose-dependent+absorption+and+elimination+of+cefadroxil+in+man&rft.jtitle=European+journal+of+clinical+pharmacology&rft.au=Garrigues%2C+T+M&rft.au=Martin%2C+U&rft.au=Peris-Ribera%2C+J+E&rft.au=Prescott%2C+L+F&rft.date=1991-01-01&rft.issn=0031-6970&rft.volume=41&rft.issue=2&rft.spage=179&rft_id=info:doi/10.1007%2FBF00265914&rft_id=info%3Apmid%2F1743250&rft_id=info%3Apmid%2F1743250&rft.externalDocID=1743250 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6970&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6970&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6970&client=summon |